Importantly, As2O3 and arsenic sulfide remarkably inhibit the NSCLC stem cells, responsible for chemotherapy resistance (e.g., cisplatin and gefitinib) and tumor recurrence via targeting EGFR pathways, ABC family transporters, and GS-X pumps. This evidence concerns the gene EGFR and non-small cell lung carcinoma.